Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
financing
4
×
life sciences
national blog main
startups
4
×
boston blog main
venture capital
boston
boston top stories
funding
san diego blog main
san diego top stories
vc
20/20 healthcare partners
accent therapeutics
aducanumab
akero therapeutics
alnylam
alzheimer's disease
amblyotech
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
apellis pharmaceuticals
aragon pharmaceuticals
arena pharmaceuticals
artie suckow
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
christian angermayer
clinical trials
corey goodman
What
new
4
×
diseases
drugs
medicines
activity
advance
approach
approvals
associated
bags
bio
biogen
biologics
biotechs
capital
clamped
companies
considered
covid
delays
deliver
develop
developing
device
dialysis
disease
dtx
economic
enclear
fast
fda
harmful
hitting
including
investing
investors
ipo
isn’t
led
limited
Language
unset
4
×
Current search:
financing
×
new
×
startups
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs